Plans to roll out a "revolutionary" breast cancer drug across the UK are "a huge step forward", according to health campaigners.
Kadcyla will be available on the cancer drugs fund, a move which will make "a significant difference" to breast cancer sufferers who have stopped responding to chemo, according to Dr Caitlin Palframan.
Kadcyla has been shown to extend life by up to six months in HER2-positive secondary breast cancer patients, and with more manageable side effects than alternative drugs.
It has the potential to provide women with a better quality of life in their final months than existing treatments, which could make a significant difference.
A thousand women die from metastatic, or secondary, breast cancer every month in the UK and this treatment has the potential to provide some of them not only with additional time, but importantly, quality time to spend with their friends and families.
More top news
The CIA has been criticised for 'live-tweeting' the killing of Osama bin Laden to mark the fifth anniversary of his death.
Argos has issued an urgent recall of certain car seats and warned parents to stop using them "immediately" over safety fears.
Two bodies found in the Himalayas have been identified as Alex Lowe and David Bridges - 16 years after they went missing.